FI943637A0 - Aryylialkoksifenoksi-imidatsoliiniyhdisteitä - Google Patents

Aryylialkoksifenoksi-imidatsoliiniyhdisteitä

Info

Publication number
FI943637A0
FI943637A0 FI943637A FI943637A FI943637A0 FI 943637 A0 FI943637 A0 FI 943637A0 FI 943637 A FI943637 A FI 943637A FI 943637 A FI943637 A FI 943637A FI 943637 A0 FI943637 A0 FI 943637A0
Authority
FI
Finland
Prior art keywords
arylalkoxifenoxiimidazolinföreningar
arylalkoxyphenoxy
anxiety
hypertension
depression
Prior art date
Application number
FI943637A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943637A (fi
Inventor
Jules Freedman
Bruce M Baron
Mark W Dudley
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/832,556 external-priority patent/US5216008A/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI943637A0 publication Critical patent/FI943637A0/fi
Publication of FI943637A publication Critical patent/FI943637A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Reinforced Plastic Materials (AREA)
  • Epoxy Resins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
FI943637A 1992-02-06 1994-08-05 Aryylialkoksifenoksi-imidatsoliiniyhdisteitä FI943637A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/832,556 US5216008A (en) 1992-02-06 1992-02-06 Arylalkoxyphenoxy-imidazoline compounds
US99017492A 1992-12-24 1992-12-24
PCT/US1993/000238 WO1993016051A1 (en) 1992-02-06 1993-01-12 Arylalkoxyphenoxy-imidazoline compounds

Publications (2)

Publication Number Publication Date
FI943637A0 true FI943637A0 (fi) 1994-08-05
FI943637A FI943637A (fi) 1994-08-05

Family

ID=27125545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943637A FI943637A (fi) 1992-02-06 1994-08-05 Aryylialkoksifenoksi-imidatsoliiniyhdisteitä

Country Status (19)

Country Link
US (1) US5407954A (es)
EP (1) EP0625969B1 (es)
JP (1) JPH07504167A (es)
KR (1) KR100276994B1 (es)
AT (1) ATE199547T1 (es)
CA (1) CA2129142A1 (es)
DE (1) DE69329994T2 (es)
DK (1) DK0625969T3 (es)
ES (1) ES2156868T3 (es)
FI (1) FI943637A (es)
GR (1) GR3035915T3 (es)
HU (1) HUT67527A (es)
IL (2) IL104600A0 (es)
MX (1) MX9300601A (es)
NO (1) NO304597B1 (es)
NZ (1) NZ246823A (es)
PT (1) PT625969E (es)
TW (1) TW366338B (es)
WO (1) WO1993016051A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000877A1 (en) * 1989-07-06 1991-01-24 Eastman Kodak Company Maleated polypropylene blends for melt-bonding applications
WO2017223473A1 (en) * 2016-06-24 2017-12-28 Ohio University Glucose transport inhibitors and methods of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695555A1 (de) * 1967-02-23 1970-07-16 Nordmark Werke Gmbh Neue Aryloxy-isoalkyl-delta2-imidazoline und deren Saeureadditionssalze sowie Verfahren zu ihrer Herstellung
CA2027530C (en) * 1989-10-20 2001-05-08 Jules Freedman W-phenoxy-heterocyclic compounds

Also Published As

Publication number Publication date
KR100276994B1 (ko) 2002-06-20
KR950700260A (ko) 1995-01-16
ES2156868T3 (es) 2001-08-01
US5407954A (en) 1995-04-18
MX9300601A (es) 1993-08-01
WO1993016051A1 (en) 1993-08-19
NO942917L (no) 1994-08-05
NO942917D0 (es) 1994-08-05
AU671270B2 (en) 1996-08-22
IL122537A0 (en) 1998-06-15
AU3442293A (en) 1993-09-03
GR3035915T3 (en) 2001-08-31
JPH07504167A (ja) 1995-05-11
DE69329994D1 (en) 2001-04-12
ATE199547T1 (de) 2001-03-15
IL104600A0 (en) 1993-06-10
CA2129142A1 (en) 1993-08-19
HUT67527A (en) 1995-04-28
EP0625969B1 (en) 2001-03-07
DE69329994T2 (de) 2001-06-28
TW366338B (en) 1999-08-11
NZ246823A (en) 1996-06-25
HU9402283D0 (en) 1994-10-28
PT625969E (pt) 2001-08-30
DK0625969T3 (da) 2001-04-30
FI943637A (fi) 1994-08-05
NO304597B1 (no) 1999-01-18
EP0625969A1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
SE9502893L (sv) Användning av kollagenas
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
DK0406211T3 (da) Fucosidase-inhibitorer
DE69230224D1 (de) Potenzierung von nmda-antagonisten
NO984245D0 (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
ATE199547T1 (de) Arylalkoxyphenoxyimidazolinverbindungen
FI953002A (fi) Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla
DK1019347T3 (da) Fremgangsmåde til syntesen af taxaner
DE69123052D1 (de) Derivate des 1-piperidinyl-alkanoylarylsulfonamids
ID26405A (id) Pemurnian karboksaldehida
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
UA40497A (uk) Спосіб лікування генералізованого катарального гінгівіту
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.
GR1001393B (el) Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.
MX9706424A (es) Uso de la moxonidina para el tratamiento de la aterosclerosis.

Legal Events

Date Code Title Description
FD Application lapsed

Free format text: AVANTONE OY